首页|期刊导航|医学信息|儿童呼吸道大肠埃希菌感染的耐药性及产ESBLs大肠埃希菌感染危险因素研究

儿童呼吸道大肠埃希菌感染的耐药性及产ESBLs大肠埃希菌感染危险因素研究OA

Study on Drug Resistance of Escherichia Coli Infection in Respiratory Tract of Children and Risk Factors of ESBLs-producing Escherichia Coli Infection

中文摘要英文摘要

目的 对儿童呼吸道大肠埃希菌感染的耐药性及产超广谱β内酰胺酶(ESBLs)大肠埃希菌感染的危险因素进行分析.方法 选择 2022 年 6 月-2024 年 5 月兴国县妇幼保健院收治的 102 例呼吸道感染患儿作为研究对象,将患者痰液标本采集送检,开展药敏试验以及细菌鉴定,针对大肠埃希菌产ESBLs菌株进行检测和筛选,根据产ESBLs大肠埃希菌检出情况分为产ESBLs组与非产ESBLs组.统计呼吸道感染患儿病原菌检出数量和种类,分析分离出的大肠埃希菌耐药情况,统计大肠埃希菌产超广谱β-内酰胺酶检测情况,比较产ESBLs组与非产ESBLs组对常用抗生素的耐药性,并对儿童呼吸道大肠埃希菌感染的耐药性及产ESBLs大肠埃希菌感染的危险因素进行分析.结果 共分离出病原菌 102 株:其中 77 株为革兰阴性菌(75.49%),25株为革兰阳性菌(24.51%).革兰阴性菌中占比前 3 位为肺炎克雷伯菌(22.55%)、大肠埃希菌(20.59%)、铜绿假单胞菌(11.76%).革兰阳性菌中占比前 3 位为金黄色葡萄球菌(13.73%)、肺炎链球菌(6.86%)、肠球菌(2.94%).分离出的大肠埃希菌耐药率大于60.00%的前 3 位为氨苄西林(90.48%)、氨苄西林-舒巴坦(85.71%)、复方新诺明(76.19%).对绝大多数药物来说,非产ESBLs菌株的耐药率低于产ESBLs菌株(P<0.05).单因素分析显示,年龄、三代头孢使用、侵袭性操作是产ESBLs大肠埃希菌感染的危险因素(P<0.05);多因素Logistic分析显示,年龄<3 岁、有侵入性操作和三代头孢使用≥3d是产ESBLs大肠埃希菌感染的独立危险因素(P<0.05).结论 大肠埃希菌是儿童呼吸道的主要致病病原菌,其耐药的重要原因之一为产ESBLs,年龄<3 岁、有侵入性操作和三代头孢使用≥3d是产ESBLs大肠埃希菌感染的独立危险因素,因此抗菌药物的选用要根据药敏试验结果合理选择.

Objective To analyze the drug resistance of Escherichia coli infection in children's respiratory tract and the risk factors of extended-spectrum β-lactamase(ESBLs)-producing Escherichia coli infection.Methods A total of 102 children with respiratory tract infection admitted to Xingguo County Maternal and Child Health Hospital from June 2022 to May 2024 were selected as the research objects.The sputum samples of the patients were collected and sent for examination,and drug sensitivity test and bacterial identification were carried out.ESBLs-producing strains of Escherichia coli were detected and screened.According to the detection of ESBLs-producing Escherichia coli,they were divided into ESBLs-producing group and non-ESBLs-producing group.The number and types of pathogenic bacteria detected in children with respiratory tract infection were counted,the drug resistance of isolated Escherichia coli was analyzed,the detection of extended-spectrum β-lactamase produced by Escherichia coli was counted,the drug resistance of ESBLs-producing group and non-ESBLs-producing group to commonly used antibiotics was compared,and the drug resistance of Escherichia coli infection in children with respiratory tract infection and the risk factors of ESBLs-producing Escherichia coli infection were analyzed.Results A total of 102 strains of pathogenic bacteria were isolated:77 strains were Gram-negative bacteria(75.49%),25 strains were Gram-positive bacteria(24.51%).The top three Gram-negative bacteria were Klebsiella pneumoniae(22.55%),Escherichia coli(20.59%)and Pseudomonas aeruginosa(11.76%).The top three Gram-positive bacteria were Staphylococcus aureus(13.73%),Streptococcus pneumoniae(6.86%)and Enterococcus(2.94%).The top three resistance rates of Escherichia coli isolated were ampicillin(90.48%),ampicillin-sulbactam(85.71%),and cotrimoxazole(76.19%).For most drugs,the resistance rate of non-ESBLs-producing strains was lower than that of ESBLs-producing strains(P<0.05).Univariate analysis showed that age,third-generation cephalosporin use,and invasive operation were risk factors for ESBLs-producing Escherichia coli infection(P<0.05).Multivariate Logistic analysis showed that age<3 years old,invasive operation and third-generation cephalosporin use≥3 days were independent risk factors for ESBLs-producing Escherichia coli infection(P<0.05).Conclusion Escherichia coli is the main pathogenic bacteria in children's respiratory tract.One of the important reasons for its drug resistance is ESBLs production.Age<3 years old,invasive operation and third-generation cephalosporin use≥3 days are independent risk factors for ESBLs-producing Escherichia coli infection.Therefore,the selection of antibiotics should be based on the results of drug sensitivity test.

罗华军

兴国县妇幼保健院检验科,江西 兴国 342400

基础医学

儿童呼吸道感染大肠埃希菌感染耐药性产ESBLs

ChildrenRespiratory tract infectionEscherichia coli infectionDrug resistanceESBLs-producing

《医学信息》 2024 (24)

99-103,5

10.3969/j.issn.1006-1959.2024.24.027

评论